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Research highlights  
 The NIS synthetase of the fungal pathogen, Rhizopus delemar was characterized 
 Rfs condenses citrate with diaminobutane to form the siderophore, rhizoferrin 
 rfs expression and its regulation by iron was confirmed in 7 Mucorales fungi  
 Rhizoferrin derivatives were produced by Rfs using substrate analogues 
 H484 is essential for activity and L544 may determine amino-specificity  
 Rfs from R. delemar is the first fungal member of the NIS family    
  
  
Abstract 
Iron is essential for growth and in low iron environments such as serum many bacteria and fungi 
secrete ferric iron-chelating molecules called siderophores. All fungi produce hydroxamate 
siderophores with the exception of Mucorales fungi, which secrete rhizoferrin, a polycarboxylate 
siderophore. Here we investigated the biosynthesis of rhizoferrin by the opportunistic human 
pathogen, Rhizopus delemar. We searched the genome of R. delemar 99-880 for a homologue of 
the bacterial NRPS-independent siderophore (NIS) protein, SfnaD that is involved in 
biosynthesis of staphyloferrin A in Staphylococcus aureus. A protein was identified in R. 
delemar with 22% identity and 37% similarity with SfnaD, containing an N-terminal IucA/IucC 
family domain, and a C-terminal conserved ferric iron reductase FhuF-like transporter domain. 
Expression of the putative fungal rhizoferrin synthetase (rfs) gene was repressed by iron. The rfs 
gene was cloned and expressed in E.coli and siderophore biosynthesis from citrate and 
diaminobutane was confirmed using high resolution LC-MS. Substrate specificity was 
investigated showing that Rfs produced AMP when oxaloacetic acid, tricarballylic acid, 
ornithine, hydroxylamine, diaminopentane and diaminopropane were employed as substrates. 
Based on the production of AMP and the presence of a mono-substituted rhizoferrin, we suggest 
that Rfs is a member of the superfamily of adenylating enzymes. We used site-directed 
mutagenesis to mutate selected conserved residues predicted to be in the Rfs active site. These 
studies revealed that H484 is essential for Rfs activity and L544 may play a role in amine 
recognition by the enzyme. This study on Rfs is the first characterization of a fungal NIS 
enzyme. Future work will determine if rhizoferrin biosynthesis is required for virulence in 
Mucorales fungi.  
 
  
1. Introduction 
 Mucormycosis is a potentially life-threatening infection in immunocompromised 
individuals caused by Mucorales fungi. The most commonly-isolated clinical specimens belong 
to the genera Rhizopus, Mucor, Cunninghamella and Lichtheimia (Alvarez et al., 2009; Park et 
al., 2011) though Rhizopus species account for up to 70% of mucormycosis infections (Roden et 
al., 2005). Some species within Rhizomucor, Saksenaea and Apophysomyces are also pathogenic 
but are less commonly isolated (Roden et al., 2005). As Mucorales fungi are opportunistic 
pathogens, they affect immunocompromised individuals such as those with hematological 
malignancies, particularly acute myeloid leukemia (Pagano et al., 1997), as well as 
hematopoietic stem cell transplant recipients (HSCT) (Sun and Singh, 2008), patients with 
uncontrolled diabetes (Roden et al., 2005) or those with elevated serum iron levels (Boelaert et 
al., 1994; Spellberg et al., 2005). Patients with diabetic ketoacidosis (DKA) are particularly 
susceptible to mucormycosis and the ability to colonize DKA patients is unique to Mucorales 
fungi; Aspergillus and Candida infections are uncommon in this patient group (Liu et al., 2010). 
Liposomal amphotericin B and posaconazole are the main antifungal agents used in 
chemotherapy (Cornely et al., 2014); however, even with treatment, mortality rates can be as 
high as 70% (Kyvernitakis et al., 2016).  
 Iron is an essential nutrient for both the host and pathogen as it is required for many 
biological processes including DNA synthesis and cellular respiration (Haas, 2003). To limit the 
growth of pathogens in vivo, serum contains iron-binding proteins such as transferrin and 
lactoferrin that maintain a very low concentration of free iron (~10-18 M). To overcome this iron 
limitation, microbes employ numerous strategies, including reductive iron assimilation (RIA) 
and uptake by a high-affinity Fe2+ transporter (Hissen et al., 2004; Li et al., 2016). In R. delemar, 
  
reduced expression of the high affinity iron permease, FTR1, resulted in attenuated infection and 
reduced mortality in DKA mice (Ibrahim et al., 2010). An alternative mechanism of iron uptake 
involves the biosynthesis and secretion of siderophores, low molecular weight organic molecules 
that are released into the environment under iron-limiting conditions to chelate ferric iron. 
Hydroxamate siderophores (named for the moiety that complexes ferric iron) are the major class 
produced by non-Mucorales fungi. In contrast, fungi within the order Mucorales have been 
shown to produce the polycarboxylate siderophore rhizoferrin (Drechsel et al., 1991; Thieken 
and Winkelmann, 1992). The chemical structure of rhizoferrin consists of a diaminobutane 
backbone linked to two citric acid moieties, with an R,R- configuration around the chiral center 
(Figure 1A) (Drechsel et al., 1992). Rhizoferrin is also produced by Francisella tularensis and 
Ralstonia (Pseudomonas) pickettii (Sullivan et al., 2006; Taraz et al., 1999). The two 
siderophores have the same molecular formula; however, bacterial rhizoferrin is an enantiomer 
of fungal rhizoferrin with an S,S configuration around the chiral center (Sullivan et al., 2006; 
Taraz et al., 1999). While the structure of R,R-rhizoferrin has been elucidated, little is known 
about its biosynthesis in Mucorales.  
 The biosynthesis of siderophores is known to occur via two main pathways. The first 
involves non-ribosomal peptide synthetases (NRPS) that catalyze the condensation of multiple 
amino acids to form siderophores. The second relies on an NRPS-independent siderophore (NIS) 
pathway. NIS enzymes function by adenylating a substrate carboxyl group for subsequent 
condensation with a polyamine or amino alcohol (Gulick, 2009). At present, there are four 
proposed classes for NIS enzymes based on their substrate specificity for polyamines or amino 
alcohols and which substrate is activated for downstream condensation (Cotton et al., 2009; 
Oves-Costales et al., 2009). Type A NIS synthetases catalyze condensation of citric acid with 
  
various amines and alcohols. The Type A’ NIS synthetase sub category catalyzes condensation 
of citric acid specifically with amines. Type B NIS synthetases are predicted to catalyze 
condensation of α-ketoglutarate with amines; however, only one such enzyme has been 
biochemically characterized (Kadi and Challis, 2009). Type C NIS synthetases are specific for 
monoamine or monoester derivatives of citric acid, or monohydroxamate derivatives of succinic 
acid, and some type C NIS synthetases are known to catalyze formation of 
oligomeric/macrocyclic siderophores (Oves-Costales et al., 2009).  
 The NIS enzymes, SfnaD and SfnaB are responsible for biosynthesis of the 
polycarboxylate siderophore, staphyloferrin A (Figure 1B) in the bacterial pathogen, 
Staphylococcus aureus. In S. aureus, SfnaD condenses one molecule of citric acid to D-ornithine 
forming a citryl-ornithine intermediate which is then used as substrate by SfnaB to condense a 
second molecule of citrate, yielding the final product staphyloferrin A (Cotton et al., 2009). 
Unlike staphyloferrin A, rhizoferrin is a symmetric molecule; therefore, we hypothesized that the 
synthesis of rhizoferrin should require only a single Sfna-like enzyme to catalyze the 
condensation of two molecules of citrate to one molecule of diaminobutane in sequential 
reactions.  
 
  
Figure 1. The chemical structures of (A) R,R-rhizoferrin and (B) S,S-staphyloferrin.  
2. Materials and Methods 
2.1 Bioinformatic analyses 
 Bioinformatic analyses were conducted using the genomic sequence of Rhizopus delemar 
(99-880) published by Ibrahim et al., 2009, and acquired from Genbank (accession: 
PRJNA13066). Genetic information about rfs (accession: RO3G_06864) was obtained from 
NCBI. Conserved domains were identified in the Rfs protein sequence using the NCBI 
Conserved Domain Database (Marchler-Bauer et al., 2015) and Blastp was used to identify Rfs 
homologs (Altschul et al., 1990). Phyre and I-TASSER (A. Roy, A. Kucukural, 2011; Kelley et 
al., 2015) were used to predict the structure of Rfs using the crystal structure of AcsD as a 
template (PDB: 2W02). PyMOL was used for structural alignments and to produce all protein 
structure figures (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC).  
 Phylogenetic analyses were carried out on NIS synthetases using a Clustal Omega 
multiple sequence alignment (Sievers et al., 2011). NIS enzymes used for the alignment are 
listed in the supplementary information. Analysis of the multiple sequence alignment was done 
using Jalview (version 2.10.1; Waterhouse et al., 2009). Phylogenetic analyses were completed 
using Geneious (version 9.1.5; Kearse et al., 2012) and a Neighbor-Joining consensus tree was 
made. Bootstrap values are indicated at branch nodes.  
2.2 Strains, media and culture conditions 
 Rhizopus delemar 99-880 was obtained from American Type Culture Collection (ATCC). 
Mucor circinelloides (UAMH 8307), Lichtheimia corymbifera (UAMH 10324) and Rhizomucor 
pusillus (UAMH 10076) were obtained from the University of Alberta Microfungus Collection 
  
and Herbarium. Syncephalastrum racemosum, Cunninghamella echinulata and Mucor heimalis 
were obtained from the culture collection at Simon Fraser University (Burnaby, Canada). To 
induce siderophore expression, fungi were grown in low iron media, Media A (20 g sucrose, 3 g 
(NH4)2SO4, 1 g K2HPO4, 1 g KH2PO4, 25 mg MgSO4• 7H2O, 10 mg CaCl2• 2H2O, 0.2 mg 
ZnSO4• 7H2O, 1 L water) or Eagle’s Minimum Essential Medium (MEM; Sigma) + 10% human 
serum (male AB positive; Sigma). Escherichia coli DH5α was used in standard cloning 
procedures. Tuner E. coli was used for protein expression. Both E. coli strains were grown on 
Luria-Bertani (LB) media (10 g tryptone, 10 g NaCl, 5 g yeast extract, 1 L water) supplemented 
with ampicillin (100 µg/ml) or kanamycin (30 µg/ml) as needed. All transformations were done 
using heat-shock and E. coli cells were made competent via incubation in 100mM CaCl2 or in 
some cases E. coli cells were made ultra-competent (Sambrook and Russell, 2006). 
2.3 Rhizoferrin quantification 
 Total siderophores were quantified using the Chrome Azurol S (CAS) assay. The CAS 
solution was prepared as previously described (Alexander and Zuberer, 1991). In a 96-well plate, 
equal volumes of CAS solution and supernatant were mixed together and incubated for 30 
minutes at room temperature. Absorbance measurements were taken at 630 nm.   
2.4 Rhizoferrin purification from culture media   
 Rhizoferrin was purified from Media A according to Drechsel et al., 1991. Briefly, fungal 
sporangiospores were inoculated into Media A (105 spores/ml) and incubated overnight at 37⁰C 
with shaking at 150 rpm. Mycelia were removed by filtration through Miracloth and the pH of 
the clarified culture medium was adjusted to 7.0. Rhizoferrin was purified through a Dowex 
50WX8 column (formate form) followed by a Biogel P2 column (Bio-Rad Laboratories). One 
  
milliliter fractions were collected and CAS-active fractions were pooled and dried by vacuum 
evaporation.  
2.5 Confirmation of rhizoferrin production in pathogenic Mucorales  
 High pressure liquid chromatography (HPLC) was used to verify the presence of 
rhizoferrin. Rhizoferrin was purified from cultures as described above and dried or freeze-dried 
samples were re-constituted in water. Ten microliters were injected into a Gemini C18 column 
(Phenomenex, 250 x 4.6 mm, 5 µm particle size) and compounds were separated using a gradient 
of 2% - 40% solvent A over 25 minutes using a flow rate of 1 ml/min. Solvent A consisted of 
acetonitrile (Fisher Scientific, HPLC grade) plus 0.2% trifluoroacetic acid (Caledon 
Laboratories). Solvent B was water. Absorbance was monitored at 220 nm. To confirm the 
presence of rhizoferrin, fractions were collected and mass spectrometry was performed using the 
Agilent 1200 HPLC and a Bruker maXis Ultra-High Resolution tandem TOF (UHR-Qq-TOF) 
mass spectrometer. Samples were introduced by flow injection via HPLC with acetonitrile/water 
(0.1 % formic acid) as mobile phase and spectra were collected under positive electrospray 
ionization (+ESI).  
2.6 Quantification of rhizoferrin production in pathogenic Mucorales 
 Fungal spores (105) were inoculated into MEM containing 10% human serum (male AB 
positive, Sigma) and incubated at 37°C with shaking. At designated time points, 50 µl aliquots 
were removed and stored at -80⁰C until the CAS assay could be run. Absorbance values were 
compared to a standard curve constructed using purified rhizoferrin and absolute amounts of 
siderophore were normalized to fungal dry weights.  
2.7 Construction of the pEHISTEV-rfs vector and rfs mutant sequences  
  
 R. delemar spores (106) were inoculated into Media A and incubated overnight at 37°C 
with shaking. Mycelia were harvested and RNA was extracted using the NucleoSpin RNA Plant 
kit (Macherey-Nagel) and cDNA was synthesized using the iScript cDNA Synthesis Kit (Bio-
Rad Laboratories). The putative rhizoferrin synthetase gene (rfs) was amplified using the primers 
BamHI-RfsRev and NotI-RfsFor (Table 1) and cloned into the multiple cloning site of the 
pEHISTEVa vector (Liu and Naismith, 2009) under control of the IPTG inducible promoter and 
in-frame with a His6 N-terminal tag. A Tobacco Etch Virus (TEV) cleavage site was present for 
posterior His-tag removal. The resulting vector, pEHISTEV-rfs was transformed into competent 
E. coli DH5α and following plasmid purification using the NucleoSpin Plasmid kit (Macherey-
Nagel) the cloned rfs gene was sequenced (Genewiz, New Jersey, USA) to confirm its fidelity.  
 Site-directed mutagenesis of the rfs gene was done using KAPA HiFi Readymix (KAPA 
Biosystems). The QuikChange Primer Design program (Agilent Technologies) was used to 
design primers for mutagenesis (Table 1). PCR reactions were carried out according to the 
manufacturers recommended protocol and products were treated with DpnI to digest parental 
template DNA. Mutant pEHISTEV-rfs plasmids were transformed into ultra-competent DH5α E. 
coli cells and selected for by growth on LB containing kanamycin. Successful mutations were 
confirmed via sequencing (Genewiz, New Jersey, USA).  
Table 1. Primers employed in this study. Mutated nucleotides are underlined and recognition 
sites for restriction endonucleases are in bold.  
Primer 
name 
Primer Sequences (5’— 3’) 
Purpose 
NotI-RfsFor GCGGCCGCTTAGATTGCCTCAGGAACACTTTGAGG Cloning  
BamHI-
RfsRev 
CTGGATCCATGCCTGTTGCCTCGAGTGAA Cloning 
SDM E209A TTCTTCTACCATAAAATGGGCACAATCGGTTGTTGAAGGAC Site 
directed 
mutagenesis 
 GTCCTTCAACAACCGATTGTGCCCATTTTATGGTAGAAGAA 
  
SDM_R354A TTGGGTATCAAAATCTCTTCTGCCCTTGCGACCGTCACACCATTC Site 
directed 
mutagenesis 
 GAATGGTGTGACGGTCGCAAGGGCAGAAGAGATTTTGATACCCAA 
SDM_H484A TATAAACGGTGTCGCATTTGAAGCTGCCGGTCAAAACACATTAG Site 
directed 
mutagenesis 
 CTAATGTGTTTTGACCGGCAGCTTCAAATGCGACACCGTTTATA 
SDM L544R CAGTTTAGAAGAGGTCTTCAAACGCTTATATCACACTTTATTCCACT Site 
directed 
mutagenesis 
 AGTGGAATAAAGTGTGATATAAGCGTTTGAAGACCTCTTCTAAACTG 
RFS-RT5’ CTGTAGCACGACCGGATATTT qPCR 
RFS-RT3’ TCCGAAATAGGTGGTGAATGG qPCR 
Act1-RT5’ TGAACAAGAAATGCAAACTGC qPCR 
Act1-RT3’ CAGTAATGACTTGACCATCAGGA qPCR 
FTR1- RT5’ GGTGGTGTCTCCTTGGGTAT qPCR 
FTR1-RT3’ AAGGAAACCGACCAAACAAC qPCR 
   
 Wildtype and mutant pEHISTEV-rfs plasmids were purified using the NucleoSpin 
Plasmid kit (Macherey-Nagel) and transformed into competent Tuner E. coli (F– ompT hsdSB 
(rB– mB–) gal dcm lacY1(DE3)) cells for protein expression.  
2.9 O-CAS bioassay for siderophore production  
 Siderophore secretion by transformed E. coli was detected on solid media with a CAS 
overlay (O-CAS) as described by Perez-Miranda et al., 2007. Briefly, Tuner E. coli transformed 
with the pEHISTEV-rfs plasmid were grown overnight at 37°C in liquid LB containing 
100µg/ml ampicillin. Five microliters of culture were spotted onto O-CAS media supplemented 
with 1 mM citric acid and 1 mM diaminobutane, with or without 1mM of the inducer, IPTG. 
Cultures were incubated for 5 days at room temperature.  
2.10 Expression and purification of Rfs 
 Rfs was expressed and purified according to Oke et al., 2010 with minor modifications. 
Briefly, Tuner E. coli cultures were incubated until an OD600 of 0.8-1.0 and then protein 
expression was induced with 1 mM IPTG overnight at 16ºC. Cells were pelleted, the supernatant 
  
was removed and cells were lysed using either glass beads (5 µm) or the One Shot cell disruptor 
(Constant Systems Ltd) in PBS, 10mM imidazole, 400mM NaCl and1 mg/ml lysozyme. Cellular 
debris was pelleted by centrifugation and Rfs was bound to Ni-NTA agarose beads (Qiagen). 
Beads were washed with PBS, 0.4 M NaCl, 20 mM imidazole and Rfs was eluted using PBS, 0.4 
M NaCl, 250 mM imidazole. Elution fractions containing Rfs were pooled, dialyzed against 50 
mM Tris (pH7.5), 0.4 M NaCl, 1 mM DTT, 0.5 mM EDTA and treated with 1 mg/ml of TEV 
protease overnight at 4⁰C. TEV protease was purified as previously described (Oke et al., 2010). 
TEV protease was removed via passage over a second Ni-NTA column and the column flow 
through and washes were pooled and concentrated using an Amicon Ultra 10K MWCO filter 
(EMD Millipore). Gel filtration was performed with a HiLoad 16/600 Superdex 200 prep grade 
column (GE Healthcare Life Sciences) using 10 mM Tris (pH 7.5) containing 0.15 M NaCl. 
Fractions containing Rfs were pooled and concentrated using an Amicon Ultra 50K MWCO 
filter (EMD Millipore). Protein concentrations were determined using the Pierce BCA protein 
assay kit (ThermoFisher Scientific). Samples were snap frozen in aliquots and stored at -80⁰C. 
To confirm protein identity and integrity, an SDS-PAGE was run and the 72 kDa band was 
excised, digested with trypsin and analyzed via mass spectrometry. 
 The oligomerization state of Rfs was determined using BlueNative gels as described by 
(Wittig et al., 2006). Acrylamide gels (4% – 13%) were run for 2 hours at 100 V at 4°C. Rfs 
(50µg) was run alone or in the presence of 1 mM citric acid and 7 mM diaminobutane or 70 mM 
DTT. Molecular masses were determined using the NativeMark™ Unstained Protein Standard 
(Life Technologies, Carlsbad, CA, USA).  
2.11 Rfs activity assay 
  
 We used a coupled 96-well plate enzyme assay to detect Rfs activity based on the 
enzymatic production of AMP coupled to lactate dehydrogenase-dependent oxidation of NADH 
as described by Schmelz et al., 2009. Rfs activity was monitored using the following conditions: 
50mM Tris (pH 8.0), 1mM ATP, 15mM MgCl2, 10mM diaminobutane, 2mM citric acid, 1.5mM 
phosphoenol pyruvate, 8.4 U pyruvate kinase, 12.6 U lactate dehydrogenase, 4 U myokinase and 
5µM Rfs. Samples were incubated at 37°C and NADH oxidation was monitored at 340 nm for 
30-60 minutes. Control samples contained either no enzyme or enzyme that had been heat 
inactivated (98°C for 10 min). Controls adding AMP to the reaction mixture were used to show 
that the other enzymes used in this assay (pyruvate kinase, lactate dehydrogenase and 
myokinase) were not limiting the rate of the reaction. To quantify the Rfs activity, a standard 
curve of NADH was generated over the linear range of 30 – 1000 µM.   
2.12 Monitoring the effect of iron on rfs expression by qPCR 
 R. delemar spores were inoculated into Media A and incubated at 37°C with shaking. 
After overnight incubation, 100µM FeCl3 was added to the cultures at time 0 and the cultures 
returned to the incubator. At specific times after iron addition, mycelia were harvested by 
filtration using filter paper and stored in RNAlater (Thermo Fisher Scientific) at 4°C overnight or 
at -20°C for longer storage. RNA extraction was done according to Warwas et al., 2010. RNA 
(400 ng) was used to synthesize cDNA with the iScript reverse transcription supermix for RT-
qPCR kit (Bio-Rad Laboratories). qPCR primers for rfs were designed using the Oligo-dT 
Analyzer and PrimerQuest (Integrated DNA Technologies). Primers for the housekeeping gene 
actin (act1), and the high-affinity iron permease, ftr1, were based on Ibrahim et al., 2010 (Table 
1). qPCR was performed using the EvaGreen qPCR Mastermix (Applied Biological Materials 
Inc.) with the following cycling parameters: 95⁰C for 10 minutes followed by 30 cycles of 95⁰C 
  
for 15 seconds and 60⁰C for 1 minute. Primer efficiencies for qPCR were comparable for act1, 
rfs and ftr1 gene primers sets (the range was 92 – 98%).  
2.13 LC-MS and high resolution mass spectrometry  
 Lyophilized enzyme reactions were re-suspended in 100 µl dH2O and separation of 
rhizoferrin, or its derivatives, was carried out using Phenomenex Luna reverse phase C18 
column (100Å, 150mm X 4.6mm).  Mobile phase A consisted of 0.1 % trifluoroacetic acid in 
water while mobile phase B was acetonitrile. A gradient separation using 2 % - 40 % mobile 
phase A was performed at a flow rate of 1 ml/min. The injection volume was 25 µL and the run 
was performed at room temperature. For high-resolution mass spectrometry, samples were 
dissolved in water and injected into an Orbitrap Velos Pro with Dionex Ultimate 3000 HPLC 
using an Xbridge C18 2.1x100mm column. The mass spectrometry data was acquired in FTMS 
(Orbitrap) mode from 150-1000m/z from 0-20mins at 30000res in positive ionisation profile 
mode (ESI+).  
2.14 Statistical analyses 
 Growth experiments and qPCR assays were performed in biological triplicates with three 
technical replicates. AMP assays were performed with three technical replicates for each 
condition tested. Data was analyzed using GraphPad Prism software. For qPCR experiments and 
AMP data, a one-way ANOVA with Tukey's multiple comparison test was used to evaluate 
significantly different gene expression levels (P < 0.001) and enzyme activity. All enzyme assays 
were performed in technical triplicates and a two-site binding model was used to fit the initial 
rate data for citric acid utilization (R2= 0.965)  
3. Results 
  
3.1 Rhizoferrin production by species of pathogenic Mucorales  
 Seven pathogenic Mucorales species including Rhizopus delemar, Mucor circinelloides, 
Lichtheimia (Absidia) corymbifera, Syncephalastrum racemosum, Mucor heimalis, Rhizomucor 
pusillus and Cunninghamella echinulata were grown in iron- limited media (Media A) overnight 
and rhizoferrin secretion was confirmed in all species using HPLC and mass spectrometry (MS; 
data not shown); a representative chromatogram and MS spectrum for R. delemar is shown in 
Figure 2. Rhizoferrin elutes with a retention time of 9.0 minutes and the main mass peaks 
correspond to rhizoferrin – 2H2O + Na+ (m/z = 423.10) and rhizoferrin – 2H2O (m/z = 401.11). 
The chrome azurol S (CAS) assay was used to quantify total rhizoferrin secretion into serum-
containing medium. Siderophore concentrations ranged from approximately 7-30 μg/mg dry 
weight for the 7 species, comparable to levels found in other filamentous fungi (Hissen et al., 
2004). Although Rhizopus delemar produced the highest amount of rhizoferrin during log phase 
(data not shown), when normalized to biomass, Lichtheimia corymbifera yielded the most 
rhizoferrin (Figure 3). Though L. corymbifera produced the greatest amount of siderophores per 
mass, we chose to characterize the NIS gene from Rhizopus delemar because Rhizopus spp. are 
the most frequent cause of mucormycosis (Lanternier et al., 2012; Lewis et al., 2013).  
  
 
Figure 2. Representative HPLC chromatograms of extracted growth medium from Rhizopus 
delemar. HPLC traces of culture extracts from R. delemar grown in (A) low iron medium and 
  
(B) iron replete medium. Arrow: the peak corresponding to rhizoferrin at 9.04 minutes. (C) Mass 
spectrum showing detection of rhizoferrin from the extract from B. The main peak corresponds 
to rhizoferrin – 2H2O + Na+ (m/z = 423.10) while the next most abundant peak is rhizoferrin – 
2H2O (m/z = 401.11).  
 
 
Figure 3. Siderophore production by 7 species of pathogenic Mucorales fungi grown in iron-
limited medium. Fungi were inoculated into MEM plus serum and grown at 37°C. Total 
siderophore content of the culture supernatant was determined during exponential phase 
(approximately 15 hours) using the CAS assay. The values are normalized to dry biomass yield 
and error bars represent the standard deviation of three independent measurements.  
3.2 Bioinformatic analyses 
 The NIS enzymes SfnaD and SfnaB are responsible for the two-step biosynthesis of the 
polycarboxylate siderophore, staphyloferrin A in Staphylococcus aureus. A homologue of SfnaD 
was identified in R. delemar (strain 99-880) with 22% identity and 37% similarity between the 
putative Rfs protein and SfnaD. The 2.1kb rfs gene was predicted to contain 6 exons and 5 
introns. The protein was predicted to be cytosolic, have 634 amino acids and contain the 
conserved N-terminal IucA/IucC family domain, responsible for biosynthesis of the carboxylate 
siderophore, aerobactin (Neilands, 1992). A C-terminal conserved ferric iron reductase FhuF-like 
transporter domain was also predicted in the protein. I-Tasser modelling (A. Roy, A. Kucukural, 
2011) generated a protein structure alignment with AcsD with 100% confidence. Based on these 
information, we proposed a biosynthetic pathway for rhizoferrin in which Rfs catalyzes the ATP-
  
dependent condensation of citrate with diaminobutane in the first step followed by the addition 
of a second citrate to the monocitryl-diaminobutane intermediate (Figure 4).   
 
Figure 4. Proposed biosynthetic pathway for fungal rhizoferrin 
3.3 Phylogenetic analysis of the putative rhizoferrin synthetase gene of Rhizopus delemar 
 Phylogenetic analysis of the predicted rfs protein resulted in good agreement with Type 
A’ NIS enzymes (Figure 5). These enzymes, including FslA and SfnaD, use citric acid and either 
diaminobutane or ornithine in the formation of bacterial siderophores (S,S-) rhizoferrin and 
staphyloferrin A, respectively.  
  
 
Figure 5. Phylogenetic analysis of rfs with bacterial NIS enzymes shows that Rfs (in bold) is a 
Type A’ NIS.  The neighbour-joining phylogenetic tree was constructed using Geneious 9.1.5 
(Kearse et al., 2012) and bootstrap values are indicated at branch nodes. NIS enzyme sequences 
used in the tree and the siderophore they biosynthesize are as follows: AsbB and AsbA - Anthrax 
siderophore biosynthesis (petrobactin); DesD -  desferrioxamine biosynthesis; AlcC - alcaligin 
biosynthesis; FslA – S, S-rhizoferrin biosynthesis; SfnaB and SfnaD – staphyloferrin A 
biosynthesis; RhbC - rhizobactin biosynthesis; IucA – aerobactin biosynthesis; AcsD and AcsC – 
achromobactin biosynthesis; PvsD – vibrioferrin biosynthesis. 
 
3.5 Regulation of rfs expression by iron 
 To determine whether the putative rfs gene expression is regulated by iron, RNA was 
extracted from R. delemar mycelia over time. qPCR analysis confirmed that rfs expression was 
repressed in iron-replete media within 30 minutes and remained at low levels of expression for 3 
h post transfer (Table 2).  Previous work using Northern blots showed that expression of ftr1, the 
Type A’ 
Type A 
Type C 
  
high affinity iron permease gene present in R. delemar, is iron-regulated (Ibrahim et al., 2010). 
Here, qPCR analysis confirmed that ftr1 expression levels are repressed under iron 
supplementation. This trend is similar to rfs expression levels, confirming the iron-regulated 
nature of rfs expression.  
3.4 Activity of Rfs overexpressed in E. coli 
 The rfs gene was successfully cloned and expressed in Tuner E. coli and E.coli 
harbouring the pEHISTEVa-rfs plasmid were capable of producing a siderophore from 
diaminobutane and citric acid. Siderophore production was detected by the presence of halos 
around colonies spotted on O-CAS media (Figure S1).  Expression conditions for Rfs in Tuner E. 
coli were optimized, and a 72 kDa protein corresponding to Rfs was purified by nickel affinity 
chromatography, followed by gel filtration (Figure S2).   
 Gel filtration indicated that Rfs formed an oligomeric complex in pH 7.5 buffer; 
however, when in pH 8.0 buffer (used in the AMP assay) and in the presence of citric acid and 
diaminobutane, Rfs adopted a monomer configuration as determined by BlueNative gel 
electrophoresis (Figure S3).  
 Rhizoferrin biosynthesis by purified Rfs from citrate and diaminobutane was confirmed 
using high resolution LC-MS (Figure 6). The main peak observed corresponds to rhizoferrin + 
H+ (m/z = 437.1393) and a peak was also observed for rhizoferrin - H2O (m/z = 419.1296). A 
peak corresponding to the mono-citryl intermediate was also observed (m/z = 263.1234). This 
suggests that Rfs forms an adenylated-citryl intermediate that is displaced from the active site 
upon nucleophilic capture of diaminobutane. These peaks were not present in control reactions 
prepared using boiled Rfs enzyme (data not shown).    
  
 
Figure 6. LC-MS/MS confirmation of rhizoferrin biosynthesis in vitro by recombinant Rfs from 
R. delemar. (A) Liquid chromatography trace of the Rfs reaction and (B) the corresponding mass 
spectra from peaks at 1.20 minutes and 3.06 minutes. Masses corresponding to rhizoferrin are 
highlighted in boxes. The mono-citryl intermediate of rhizoferrin was found (m/z = 263.1234) as 
well as the full compound (rhizoferrin + H+ (m/z = 437.1393)). A dehydrated form of rhizoferrin 
was also present (rhizoferrin - H2O (m/z = 419.1296)).  
 
3.6 Recombinant Rfs kinetic analysis  
 A coupled AMP production/NADH oxidation assay (Schmelz et al., 2009) was used to 
monitor Rfs activity. First, we demonstrated that other enzymes used in this coupled enzyme 
assay, myokinase and lactate dehydrogenase, were not rate limiting; therefore, the rate-limiting 
step in all reactions was the Rfs catalysis (Figure S4). Kinetic analysis of the fungal NIS showed 
that Rfs efficiently used diaminobutane and citric acid as substrates. Rfs kinetic parameters were 
determined using the initial rate of citric acid utilization over a range of 0.05 - 5 mM. 
Concentrations of 20 mM citric acid and above were found to be inhibitory to the downstream 
enzymes in the AMP assay (data not shown) and were not included in data analysis. The best fit 
1.20 mins 
3.06 mins 
  
to our data was found using a two-site binding model yielding Vmax and Kd values for two 
isozymes. For the first species the Vmax and Kd were 9.03 ± 1.47 μM/min and 0.03 ± 0.01 mM, 
respectively; for the second species the Vmax and Kd were 24.46 ± 8.04 μM/min and 4.97 ± 3.73 
mM, respectively. As this model gave the best fit for citric acid utilization, it suggests that Rfs 
has two binding sites for citric acid adenylation; however, bioinformatic analyses do not predict 
these two sites to be within one enzyme implying that Rfs may be functional as both a monomer 
and dimer under the conditions tested. While BlueNative gel analysis (Figure S3) shows 
predominantly a monomer at pH 8.0 in the presence of substrates, there may be assembly and/or 
disassembly of the more favourable form over time that would not be seen during gel analysis. 
Furthermore, the two-site binding model implies that the dimer to monomer transition, and vice-
versa, is slow relative to kinetics; however, as dimers were not observed in the gel analysis 
(Figure S3), the ratio of monomer to dimer cannot be determined. Therefore, kcat and kcat/Km 
cannot be calculated.   
3.7 Activity of recombinant Rfs with different substrates 
 When analyzing substrate derivative data, Km and Vmax values could not be determined 
because linear regression of the NADH consumption versus time data did not produce a random 
plot of the residuals (data not shown). Instead, we compared the substrate derivatives by 
measuring the time required for Rfs to consume 50% of the initial NADH present. . Shorter 
periods of time indicated faster consumption of NADH and therefore, more rapid Rfs activity. 
 The activity of Rfs using the native substrates was compared with equimolar 
concentrations of various analogues of both citrate and diaminobutane. The following 
compounds were active in the assay (from highest to lowest activity): oxaloacetic acid, 
diaminopropane, diaminobutane, diaminopentane, tricarballylic acid, hydroxylamine and 
  
ornithine (Figure 7). Negligible activity was detected with butylamine, succinic acid, α-keto 
glutaric acid, 4-amino-1-butanol and serine. Thus, fungal Rfs was able to use both oxaloacetic 
acid and tricarballylic acid as citrate analogues. To determine whether Rfs completed the 
condensation of the analogues, LC-MS/MS was performed on lyophilized enzyme reactions. Rfs 
formed only a mono-substituted intermediate with oxaloacetic acid and diaminopentane whereas 
both mono-citryl intermediates and full rhizoferrin derivatives were detected when 
diaminopropane, and ornithine were used as substrates. Tricarballylic acid only formed a 
rhizoferrin derivative; no mono-substituted intermediate was detected in this reaction (Table 2).  
 
 
Figure 7. Activity of Rfs using various substrate derivatives. Data is presented as the amount of 
time required to reach 50% NADH consumption; therefore smaller values indicated faster 
NADH consumption. The data represent the mean of three measurements and error bars indicate 
the standard deviation. A one-way ANOVA was used to evaluate significantly different means. 
Means with the same letter are not significantly different from each other (P<0.001).  
 
 
  
Table 2. Expected and actual masses or rhizoferrin derivatives obtained from mass spectroscopy analysis of Rfs reactions. Reactions 
where no product was observed show only the expected mass in brackets.  
 
Diaminobutane + 
Citric acid 
Diaminopentane + 
Citric acid 
Diaminopropane + 
Citric acid 
Ornithine + Citric 
acid 
Oxaloacetic acid + 
Diaminobutane 
Tricarballylic acid + 
Diaminobutane 
 
Observed mass 
(expected mass) 
Observed mass 
(expected mass) 
Observed mass 
(expected mass) 
Observed mass 
(expected mass) 
Observed mass 
(expected mass) 
Observed mass 
(expected mass) 
M + H 437.1403 
(437.1402) 
451.1556 (451.1558) 423.1245 (423.1245) 
481.1303 
(481.1303) 
(317.0979) 405.1504 (405.1503) 
M - H2O + H (419.1296) (433.1452) 405.1142 (405.1139) (463.1197) (299.0873) 387.1399 (387.1397) 
M - citryl + H 263.128 (263.124) 277.1392 (277.1399) 249.1082 (249.1086) 
307.1130 
(307.1141) 
143.0815 (143.082) (231.1344) 
 
  
3.8 Site-directed mutagenesis of Rfs 
 Based on multiple sequence alignments of NIS proteins from bacteria (Figure S6), we 
used site-directed mutagenesis to mutate selected conserved residues in the Rfs active site 
(Figure S7). Protein modelling showed that the amino acids chosen for mutation aligned with 
residues found to be critical in the NIS enzyme, AcsD (Schmelz et al., 2009). Specifically, four 
mutations were made in Rfs: arginine at position 354 (R354), histidine at position 484 (H484) 
and glutamate at position 209 (E209) were all mutated to alanine residues, whereas leucine at 
position 544 was mutated to an arginine (L544R) (Figure S6). R354A and H484A were chosen 
because these amino acids are predicted to be involved in citrate and ATP recognition in the 
active site of AcsD. L544R was constructed such that the active site in Rfs mimicked AcsD 
which is able to use serine (Schmelz et al., 2011). E209 was one of two resides conserved across 
all NIS enzymes and is located on the periphery of the enzyme active site (Figure S7). However, 
expression of the E209A protein was poor in multiple bacterial expression hosts under various 
conditions (data not shown). These data suggest that E209 is a conserved residue that is required 
for proper folding of Rfs and possibly all NIS enzymes. The R354A mutation did not alter 
NADH consumption compared to the wild type enzyme (Figure 8). In contrast, H484A was 
inactive, demonstrating a crucial role in catalysis and/or substrate binding. Using the native 
substrates diaminobutane and citric acid, L544R had similar activity to the wildtype enzyme. 
Interestingly, when serine was added in place of diaminobutane, the wild type enzyme had zero 
activity but L544R was able to accommodate serine in the active site and consumed NADH at a 
significantly higher rate (Figure 8). This enhanced activity shows that we were successful in 
expanding the substrate binding pocket of Rfs and may indicate that the residue at position 544 
in Rfs plays a role in governing the amino-substrate specificity of NIS enzymes.  
  
 
 
 
Figure 8. Activity of wild type and mutant Rfs enzymes. Activity of the wild type and Rfs 
mutants was assessed using the AMP assay with the native substrates, diaminobutane and citric 
acid, or with serine. H484A displayed very little NADH consumption, while R354A used 
diaminobutane and citric acid as substrates and consumed NADH at the same rate as the wild 
type enzyme. L544R can use diaminobutane, citric acid and serine as substrates. The data 
represent the mean of three measurements and error bars indicate the standard deviation. A one-
way ANOVA and Tukey’s Multiple Comparison test were used to evaluate significantly 
different means. Means with the same letter are not significantly different from each other 
(P<0.001).  
 
4. Discussion  
 This study confirmed and quantified rhizoferrin secretion in seven pathogenic species of 
Mucorales fungi. While rhizoferrin production has been confirmed in Mucor mucedo, Rhizopus 
microsporus var. rhizopodiformis and Cunninghamella elegans (Thieken and Winkelmann, 
1992), this is the first confirmation of rhizoferrin production in Rhizopus delemar, Mucor 
circinelloides, Lichtheimia (Absidia) corymbifera, Syncephalastrum racemosum, Mucor 
heimalis, Rhizomucor pusillus and Cunninghamella echinulata. We have also identified and 
characterized the NIS synthetase responsible for rhizoferrin biosynthesis (Rfs) in the fungal 
pathogen Rhizopus delemar. Of the Mucorales genomes that have been sequenced, Rfs 
homologues were identified in the following species based on the presence of the conserved 
IucA/IucC domain (Geer et al., 2002): L. corymbifera, L. ramosa, Mucor ambiguus, M. 
  
circinelloides f. lusitanicus, M. circinelloides f. circinelloides, Rhizopus microsporus, Absidia 
glauca, Parasitella parasitica, Choanephora cucurbitarum and Phycomyces blakesleeanus. 
Future work will aim to eliminate expression of rfs in one of these Mucorales species to 
determine the role Rfs plays in virulence.  
 The fungal NIS synthetase characterized in this study was shown to be part of the Type 
A’ NIS family and its expression is repressed by iron. Based on the work described here, we 
proposed a mechanism for rhizoferrin biosynthesis involving ATP-dependent formation of a 
mono-citryl rhizoferrin intermediate using 1 molecule of citric acid and 1 molecule of 
diaminobutane (Figure 4). The intermediate is then condensed with another molecule of citric 
acid to form rhizoferrin, using Mg2+ as a cofactor and 2 molecules of ATP in total. A similar 
mechanism has been described for the NIS enzyme, AcsD (Schmelz et al., 2009). In AcsD, 
adenylation of the carboxylate group in citrate results in an enzyme-bound acyl adenylate 
intermediate that is condensed with an amine/alcohol resulting in displacement of AMP and the 
formation of the amide/ester product. This mechanism has also been confirmed in the NIS 
enzymes SbnE, SbnC and SbnF, which are involved in biosynthesis of the carboxylate 
siderophore, staphyloferrin B (Cheung et al., 2009). In this reaction, a citryl adenylate 
intermediate is formed using the Type A NIS enzyme, SbnE, followed by condensation with 2,3 
diaminopropionic acid. This intermediate is decarboxylated and the now citryl-diaminoethane 
intermediate is adenylated by the Type C NIS enzyme, SbnF and condensed with 
diaminopropionic acid again. The full staphyloferrin B compound is created when α-
ketoglutarate is added by the Type B NIS synthetase, SbnC (Cheung et al., 2009). This 
mechanism of action makes AcsD, SbnE, SbnF and SbnC members  of the superfamily of 
adenylating enzymes (Schmelz et al., 2009). Based on their sequence similarity, the production 
  
of AMP in the assay and LC-MS detection of the mono-citryl rhizoferrin intermediate, we 
propose that Rfs is a member of the superfamily of adenylating enzymes and the first fungal 
member of the NIS family.   
 Rfs is capable of using citric acid derivatives as well as diaminobutane derivatives as 
substrates. Rfs used oxaloacetic acid and tricarballylic acid as citric acid derivatives and 
diaminopropane, diaminopentane, hydroxylamine, and ornithine as diaminobutane derivatives. 
Interestingly, Rfs was capable of using these derivatives to form di-substituted rhizoferrin 
derivatives, with the exception of oxaloacetic acid and diaminopentane which formed mono-
substituted compounds. In contrast, Tschierske et al. (1996) produced rhizoferrin analogues 
using directed fermentation with C. elegans, and gas chromatography and mass spectrometry 
confirmed the production of a di-substituted diaminopentane derivative; a derivative using 
ornithine was not detected and only the mono-substituted tricarballylic acid derivative was found 
in very low yield. Similar to our study, Tschierske et al. (1996) found that diaminobutane 
derivatives were more readily incorporated to make rhizoferrin analogues compared to citric acid 
derivatives. This suggests that citrate recognition in the enzyme active site is stricter compared to 
the choice of nucleophile. However, it is worth noting that only a few substrate combinations 
were analyzed and more experiments are required to further elucidate the recognition mechanism 
and catalytic kinetics with different substrate derivatives. 
 To investigate the amino acids crucial for Rfs functioning, several mutants were made. 
Of these mutants, H484A was shown to be essential, most likely involved in ATP binding, as 
seen in AscD (Schmelz et al., 2009). Additionally, we mutated L544 to an arginine, mimicking 
the AcsD binding site for serine, a substrate not used by wild type Rfs. We showed that L544R 
was catalytic active using diaminobutane in the formation of rhizoferrin. Interestingly, L544R 
  
successfully utilized serine as a substrate suggesting that L544 does play a role in nucleophile 
recognition. Experiments are underway to obtain a crystal structure for Rfs to confirm this 
hypothesis. 
 Rhizoferrin secretion has been identified in bacteria, including Francisella tularensis, 
Ralstonia pickettii, Morganella morganii and recently, in Legionella pneumophila  (Braun et al., 
1996; Burnside et al., 2015; Sullivan et al., 2006; Taraz et al., 1999). The molecular formula of 
rhizoferrin isolated from bacteria and fungi is identical but they are enantiomers (Figure 1) 
(Drechsel et al., 1992; Taraz et al., 1999). Biosynthesis of bacterial rhizoferrin is catalyzed by the 
NIS enzyme, FslA in F. tularensis (Sullivan et al., 2006) and expression of fslA was shown to be 
iron regulated and transcription occurred as part of an operon (Kiss et al., 2008). This 
phenomenon was also observed in the biosynthesis of other polycarboxylate siderophores 
including, staphyloferrin A (Cotton et al., 2009), staphyloferrin B (Hannauer et al., 2015), 
achromobactin (Berti and Thomas, 2009), vibrioferrin (Tanabe et al., 2003) and petrobactin (Lee 
et al., 2007). Typically, genes transcribed as part of this operon are involved in secretion of the 
desferri-siderophore (iron free) or uptake of the ferrated compound. Bioinformatic analyses of 
the locus surrounding rfs in R. delemar did not reveal any genes related to metal transport (data 
not shown). Uptake of ferrated rhizoferrin has been characterized in the bacteria M. morganii and 
L. pneumophila. In L. pneumophila the inner membrane transporter, LbtB was shown to be 
involved in export of the desferri-siderophore, while the outer and inner membrane proteins, 
LbtU and LbtC were shown to mediate ferri-rhizoferrin uptake (Burnside et al., 2015). In M. 
morganii, uptake of ferrated rhizoferrin was shown to occur via the RumA and RumB proteins 
(Braun et al., 1996). A search of the R. delemar proteome did not uncover any homologues (with 
>16% sequence coverage) to LbtB, LbtU or LbtC. A hypothetical homolog was found for the 
  
rumB protein using DELTA-BLAST (Boratyn et al., 2012); the match was weak with 23% 
coverage and 28% identity for rumB. As no significant  homologues are present in R. delemar, 
uptake of ferrated-rhizoferrin in Mucorales fungi may occur via a novel mechanism.  
 This work has successfully identified and characterized the enzyme responsible for 
rhizoferrin biosynthesis in the pathogenic fungus Rhizopus delemar. NIS enzymes are not 
present in humans and therefore Rfs represents a potential target for development of novel 
antifungal agents. However, first the role of Rfs in the virulence of Mucorales fungi must be 
confirmed in animal models of mucormycosis. In addition, some Rhizopus spp. are plant 
pathogens and, because iron acquisition in the environment is important for pathogen growth, 
fungal NIS enzymes may also represent a target for control agents in agriculture. 
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